Abstract Background Plasma ceramides (Cer), a subset of bioactive lipids, have mechanistic
links to atherosclerotic coronary artery disease (CAD) pathogenesis and are related to major …

Aims This study investigated the association of circulating ceramides in patients with
comorbid acute coronary syndrome and type 2 diabetes mellitus (ACS-DM). Methods A total …

Developed by researchers at Mayo Clinic in the USA, the test measures blood
concentrations of plasma ceramides, a class of lipids that are highly linked to cardiovascular …

The Mayo Clinic recently introduced a diagnostic test that quantifies plasma ceramides in
order to identify patients at risk of major adverse cardiac events. By comparing recent …

Aims The aim was to study the prognostic value of plasma ceramides (Cer) as
cardiovascular death (CV death) markers in three independent coronary artery disease …

Background Sphingolipids are a family of circulating lipids with regulatory and signaling
roles that are strongly associated with both eGFR and cardiovascular disease. Patients with …

Background Recent population-based studies identified plasma sphingolipids as
independent predictors of increased cardiovascular disease (CVD) morbidity and mortality …

Background Recent studies have suggested that specific plasma ceramides are
independently associated with major adverse cardiovascular events in patients with …

Background Obesity is associated with increased cardiovascular risk; however, the potential
role of dysregulations in the adipose tissue (AT) metabolome is unknown. Objectives The …

Plasma ceramides (CER), a class of sphingolipid molecules, have been identified as
markers of future cardiovascular (CV) events and measurement of certain ceramide species …